Hypertrophic Cardiomyopathy Clinical Trial

Functional Capacity and Quality of Life Following Septal Myectomy in Patients With HCM

Summary

Investigators aim to assess changes in exercise capacity and quality of life after septal myectomy in patient with hypertrophic cardiomyopathy.

View Full Description

Full Description

The objective of this study is to examine change in quality of life and functional capacity as respectively measured by, Quality of Life Questionnaires and six-minute walk test distance, following septal myectomy in patients with obstructive hypertrophic cardiomyopathy, as compared to prior to surgery.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Scheduled to undergo septal myectomy.
Established diagnosis of obstructive HCM defined as:

LVH Thickness ≥15mm left ventricular outflow tract gradient ≥50mmHg

Exclusion Criteria:

Prior septal myectomy or alcohol septal ablation
Prior myocardial infarction
Uncontrolled arrhythmias including ventricular tachycardia and atrial fibrillation
Uncontrolled hypertension
Angiographically documented coronary stenosis >50%, if available at time of screening
Inability to provide informed consent
Inability to walk without assistive devices
Peripheral artery disease with claudication

Study is for people with:

Hypertrophic Cardiomyopathy

Estimated Enrollment:

177

Study ID:

NCT03092843

Recruitment Status:

Completed

Sponsor:

The Cleveland Clinic

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Cleveland Clinic
Cleveland Ohio, 44195, United States

How clear is this clinincal trial information?

Study is for people with:

Hypertrophic Cardiomyopathy

Estimated Enrollment:

177

Study ID:

NCT03092843

Recruitment Status:

Completed

Sponsor:


The Cleveland Clinic

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.